EOHSEP
MCID: HYP806
MIFTS: 32

Hypertension, Early-Onset, Autosomal Dominant, with Severe Exacerbation in Pregnancy (EOHSEP)

Categories: Genetic diseases

Aliases & Classifications for Hypertension, Early-Onset, Autosomal Dominant, with Severe...

MalaCards integrated aliases for Hypertension, Early-Onset, Autosomal Dominant, with Severe Exacerbation in Pregnancy:

Name: Hypertension, Early-Onset, Autosomal Dominant, with Severe Exacerbation in Pregnancy 56 29 39
Hypertension, Early-Onset, Autosomal Dominant, with Exacerbation in Pregnancy 56 13 6
Early-Onset Hypertension with Severe Exacerbation in Pregnancy 73
Hypertensive Disease 71
Eohsep 73

Characteristics:

HPO:

31
hypertension, early-onset, autosomal dominant, with severe exacerbation in pregnancy:
Inheritance autosomal dominant inheritance


Classifications:



External Ids:

OMIM 56 605115
MeSH 43 D006973
MedGen 41 C1854631
UMLS 71 C0020538

Summaries for Hypertension, Early-Onset, Autosomal Dominant, with Severe...

UniProtKB/Swiss-Prot : 73 Early-onset hypertension with severe exacerbation in pregnancy: Inheritance is autosomal dominant. The disease is characterized by the onset of severe hypertension before the age of 20, and by suppression of aldosterone secretion.

MalaCards based summary : Hypertension, Early-Onset, Autosomal Dominant, with Severe Exacerbation in Pregnancy, is also known as hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy, and has symptoms including edema, tremor and chest pain. An important gene associated with Hypertension, Early-Onset, Autosomal Dominant, with Severe Exacerbation in Pregnancy is NR3C2 (Nuclear Receptor Subfamily 3 Group C Member 2). The drugs Estradiol and Cyproterone Acetate have been mentioned in the context of this disorder. Affiliated tissues include heart, kidney and endothelial, and related phenotypes are hypertension and decreased circulating aldosterone level

More information from OMIM: 605115

Related Diseases for Hypertension, Early-Onset, Autosomal Dominant, with Severe...

Symptoms & Phenotypes for Hypertension, Early-Onset, Autosomal Dominant, with Severe...

Human phenotypes related to Hypertension, Early-Onset, Autosomal Dominant, with Severe Exacerbation in Pregnancy:

31 (showing 4, show less)
# Description HPO Frequency HPO Source Accession
1 hypertension 31 HP:0000822
2 decreased circulating aldosterone level 31 HP:0004319
3 decreased circulating renin level 31 HP:0003351
4 maternal hypertension 31 HP:0008071

Clinical features from OMIM:

605115

UMLS symptoms related to Hypertension, Early-Onset, Autosomal Dominant, with Severe Exacerbation in Pregnancy:


edema, tremor, chest pain, angina pectoris, equilibration disorder

Drugs & Therapeutics for Hypertension, Early-Onset, Autosomal Dominant, with Severe...

Drugs for Hypertension, Early-Onset, Autosomal Dominant, with Severe Exacerbation in Pregnancy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 76, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Estradiol Approved, Investigational, Vet_approved Phase 4 50-28-2 5757
2
Cyproterone Acetate Approved, Investigational Phase 4 427-51-0
3
Ethinyl Estradiol Approved Phase 4 57-63-6 5991
4
Polyestradiol phosphate Approved Phase 4 28014-46-2
5
Phenylephrine Approved Phase 4 59-42-7 6041
6
Oxymetazoline Approved, Investigational Phase 4 1491-59-4 4636
7
Remifentanil Approved Phase 4 132875-61-7 60815
8
Thiopental Approved, Vet_approved Phase 4 76-75-5 3000715
9
Morphine Approved, Investigational Phase 4 57-27-2 5288826
10
Isoflurane Approved, Vet_approved Phase 4 26675-46-7 3763
11
Atracurium Approved, Experimental, Investigational Phase 4 64228-79-1 47319
12
Nifedipine Approved Phase 4 21829-25-4 4485
13
Labetalol Approved Phase 4 36894-69-6 3869
14
tannic acid Approved Phase 4 1401-55-4
15
Benzocaine Approved, Investigational Phase 4 94-09-7, 1994-09-7 2337
16
Ketorolac Approved Phase 4 66635-83-4, 74103-06-3 3826
17
Acetaminophen Approved Phase 4 103-90-2 1983
18
Ibuprofen Approved Phase 4 15687-27-1 3672
19 Estradiol 17 beta-cypionate Phase 4
20 Contraceptive Agents, Male Phase 4
21 Androgen Antagonists Phase 4
22 Contraceptive Agents Phase 4
23 Estradiol 3-benzoate Phase 4
24 Androgens Phase 4
25
Cyproterone Phase 4 2098-66-0 5284537
26 Cyproterone acetate, ethinyl estradiol drug combination Phase 4
27 Antihypertensive Agents Phase 4
28 Anesthetics Phase 4
29 Calcium, Dietary Phase 4
30 Analgesics, Opioid Phase 4
31 Adrenergic alpha-Antagonists Phase 4
32 Adrenergic Agents Phase 4
33 Adrenergic Antagonists Phase 4
34 Vasodilator Agents Phase 4
35 Adrenergic beta-Antagonists Phase 4
36 Sympathomimetics Phase 4
37 Adrenergic alpha-1 Receptor Antagonists Phase 4
38 Neurotransmitter Agents Phase 4
39 calcium channel blockers Phase 4
40 Analgesics Phase 4
41 Analgesics, Non-Narcotic Phase 4
42 Narcotics Phase 4
43 Cyclooxygenase Inhibitors Phase 4
44 Anti-Inflammatory Agents Phase 4
45 Antirheumatic Agents Phase 4
46 Anti-Inflammatory Agents, Non-Steroidal Phase 4
47
Calcium Nutraceutical Phase 4 7440-70-2 271
48
Valsartan Approved, Investigational Phase 3 137862-53-4 60846
49 Potassium Supplement Phase 1, Phase 2
50
Olmesartan Approved, Investigational 144689-24-7, 144689-63-4 158781 130881
51
Amlodipine Approved 88150-42-9 2162
52
Hydrochlorothiazide Approved, Vet_approved 58-93-5 3639
53
Misoprostol Approved 59122-46-2 5282381
54
Oxytocin Approved, Vet_approved 50-56-6 53477758 439302
55
Progesterone Approved, Vet_approved Early Phase 1 57-83-0 5994
56
Vitamin D3 Approved, Nutraceutical 67-97-0 5280795 6221
57
Vitamin D Approved, Nutraceutical, Vet_approved 1406-16-2
58
Melatonin Approved, Nutraceutical, Vet_approved 73-31-4 896
59 Mineralocorticoid Receptor Antagonists
60 Mineralocorticoids
61
Olmesartan medoxomil 144689-63-4 130881
62 Micronutrients
63 Trace Elements
64 Calciferol
65 Vitamins
66 Nutrients
67 Antacids
68 Anti-Ulcer Agents
69 Gastrointestinal Agents
70 Liver Extracts
71 Insulin, Globin Zinc
72 insulin
73 Hormones Early Phase 1
74 Hormone Antagonists Early Phase 1
75 Tocolytic Agents Early Phase 1
76 Progestins Early Phase 1

Interventional clinical trials:

(showing 32, show less)
# Name Status NCT ID Phase Drugs
1 The Effect of Diane-35 Pretreatment on Endocrine and Clinical Profile for Patients With Polycystic Ovary Syndrome Undergoing In-vitro Fertilization Unknown status NCT01752270 Phase 4 Diane-35 pretreatment;Diane-35 pretreatment
2 Effect of Acute Arterial Hypertension on Morphine's Requirements and Postsurgical Pain. Completed NCT01897155 Phase 4
3 Ethnic Differences in Anti-Hypertensive Medication Response Among Pregnant and Postpartum Patients Completed NCT03506724 Phase 4 Nifedipine;Labetalol
4 A Randomized Trial Comparing Oral Misoprostol Alone With Oral Misoprostol Followed by Oxytocin in Women Induced for Hypertension of Pregnancy Recruiting NCT03749902 Phase 4 Oral misoprostol;Oxytocin
5 Effect of Non-steroidal Anti-inflammatory Use on Blood Pressure in Women With Hypertensive Disorders of Pregnancy: A Randomized Open Label Trial Recruiting NCT03824119 Phase 4 Ibuprofen 600 mg
6 Randomized, Double Blind, Active-controlled, Parallel Study to Analyse Effects of the Combination of Aliskiren and Valsartan on the Vascular Structure and Function of Retinal Vessels Completed NCT01318395 Phase 3 Aliskiren;Placebo
7 The Effect of Potatoes on Potassium Retention, Acid Base Balance, and Blood Pressure Unknown status NCT02697708 Phase 1, Phase 2
8 A Randomized, Double-blind, Placebo-controlled, Cross-over, Multi-center Study Assessing the Safety, Tolerability and Efficacy of SER100 10 mg s.c. Twice Daily for 2 Days in Patients With Isolated Systolic Hypertension Insufficiently Treated With One or More Anti-hypertensives. Completed NCT01987284 Phase 2 SER100;Placebo
9 A Study on Medication Adherence and "True" Resistance in Patients Referred to a Medical Outpatient Department in Germany With the Diagnosis "Resistant Hypertension". Unknown status NCT02128386
10 Acupuncture as Applied Technology to Nursing Care Adult Hypertensive: An Experimental Study. Unknown status NCT02530853
11 Effect of Vitamin D3 on Cardiovascular Risk Factors: a Randomized Trial in Human Completed NCT01501916
12 Investigation of the Serum MUC3 Protein Levels in Gestational Hypertensive Disease (Preeclampsia-Eclampsia, Pregnancy Induced Hypertension, and HELLP Syndrome) Compared With Normal Pregnancy Completed NCT04421183
13 A Multicentre Cross-sectional Study of the Prevalence of Hypertensive Disease in Patients Presenting for Elective Surgery in the Western Cape Completed NCT03157661
14 Understanding the Mechanisms of Progressive Decrease in Blood Pressure After Renal Nerve Ablation Completed NCT01442883
15 Hypertension of Our Patients: Knowledge, Control, Comorbidity Completed NCT01998022
16 Maturational Changes in Cardiac Structures -- Blood Pressure Relationship -- SCOR in Hypertension Completed NCT00005469
17 Renal Denervation in Treatment Resistant Hypertension Completed NCT01687725
18 Cloud BP System Integrated With CPOE Improves Self-Management of the Hypertensive Patients: A Randomized Controlled Trial Study Completed NCT02175511
19 Activating Mass Media for Salt Reduction Program by Using Media Reporters as Research Investigators in a Randomized Controlled Trial Completed NCT03074851
20 Circulating Melatonin and 6-hydroxymelatonin Levels During Pregnancy Completed NCT03014245
21 Collection of Samples From Pregnant Women for the Evaluation of Preeclampsia (Pre-E) Biomarkers Recruiting NCT02780414
22 The Use of the Cerebro-placental Ratio to Predict Adverse Outcomes in Pregnancies Complicated by Gestational Diabetes Recruiting NCT03072563
23 Use of Meditation as a Complementary Therapy in the Treatment of Gestational Hypertension Recruiting NCT03873194
24 EASL: European Registry of Liver Disease in Pregnancy Recruiting NCT03834285
25 An Alongside Qualitative Study Exploring Patients' and Health Care Professionals' Expectations and Experiences of Labour Induction With Misoprostol and Oxytocin for Hypertension in Pregnancy in India Active, not recruiting NCT04037683 Misoprostol Oral Tablet;Oxytocin
26 A Systematic Review of Factors Associated With Pulmonary Arterial Hypertension in Systemic Sclerosis Active, not recruiting NCT03889509
27 Randomized Trial to Compare Surgical and Medical Treatments for Type 2 Diabetes (Triabetes) - Alliance of Randomized Trials of Medicine vs. Metabolic Surgery in Type 2 Diabetes ARMMST2D) Active, not recruiting NCT01047735
28 Observational Multicenter Study Lasting 12 Months to Determine the Prevalence of Pulmonary Hypertension (PAH) in Patients With Thalassemia Major and Intermedia and Verify the Suitability of Common Diagnostic Criteria in This Population Active, not recruiting NCT01496963
29 Antenatal Management Based on Transvaginal Ultrasound Cervical Length Screening for Preventing Preterm Birth Not yet recruiting NCT04104984 Early Phase 1 Progesterone Vaginal Suppository;Tocolytic Agents
30 Bioimpedance In Pregnancy and Labour: A Fluid Balance Concept Study. Not yet recruiting NCT03823820
31 The Impact of Interleukin-10 in the Invasion Capacity and Immunoregulation During Pregnancy: the Implications of Pathogenesis of Pre-Eclampsia. Terminated NCT00154934
32 Evaluation of Transcranial Doppler Vasoconstrictor Vasoreactivity During General Anesthesia in Hypertensive Patients Withdrawn NCT03897790

Search NIH Clinical Center for Hypertension, Early-Onset, Autosomal Dominant, with Severe Exacerbation in Pregnancy

Inferred drug relations via UMLS 71 / NDF-RT 50 :


Acebutolol
Acebutolol Hydrochloride
Amiloride
Amiloride Hydrochloride
Amlodipine
Amlodipine Besylate
Angelica sinensis preparation
Antihypertensives, Other
Atenolol
benazepril
Benazepril hydrochloride
Bendroflumethiazide
benzthiazide
Bepridil
Bepridil hydrochloride
Betaxolol
Betaxolol Hydrochloride
Bisoprolol
Bisoprolol Fumarate
Bumetanide
candesartan
candesartan cilexetil
Carteolol
Carteolol Hydrochloride
carvedilol
carvedilol phosphate
Chlorothiazide
Chlorothiazide sodium
Chlorthalidone
Clonidine
CLONIDINE HCL PWDR
Clonidine Hydrochloride
coenzyme Q10
cyclothiazide
deserpidine
Diltiazem
Diltiazem Hydrochloride
Diltiazem maleate
DITIAZ
Doxazosin
Doxazosin Mesylate
eplerenone
eprosartan
Eprosartan mesylate
esmolol
Esmolol hydrochloride
Ethacrynate Sodium
Ethacrynic Acid
Felodipine
Fish Oils
Fosinopril
Fosinopril Sodium
Furosemide
Guanabenz
Guanabenz Acetate
guanadrel
Guanadrel sulfate
Guanethidine
Guanethidine Monosulfate
Guanfacine
Guanfacine Hydrochloride
Hydrochlorothiazide
Hydroflumethiazide
Indapamide
irbesartan
Isradipine
Lisinopril
Losartan
Losartan Potassium
Methyclothiazide
Methyldopa
Methyldopate hydrochloride
Metolazone
Metoprolol
metoprolol succinate
Metoprolol Tartrate
Mibefradil
Mibefradil Dihydrochloride
moexipril
Moexipril hydrochloride
Nadolol
Nicardipine
Nicardipine hydrochloride
Nifedipine
Nisoldipine
Oil of garlic
olmesartan
Olmesartan medoxomil
Penbutolol
Penbutolol Sulfate
Perindopril
Perindopril arginine
Perindopril Erbumine
Pindolol
Polythiazide
Prazosin
Prazosin hydrochloride
Propranolol
Propranolol Hydrochloride
quinapril
Quinapril hydrochloride
quinethazone
Ramipril
Reserpine
Spironolactone
SPIRONOLACTONE PWDR
telmisartan
Terazosin
terazosin hydrochloride
Timolol
Timolol Hemihydrate
Timolol Maleate
torsemide
trandolapril
Triamterene
Trichlormethiazide
valsartan
Verapamil
Verapamil hydrochloride

Genetic Tests for Hypertension, Early-Onset, Autosomal Dominant, with Severe...

Genetic tests related to Hypertension, Early-Onset, Autosomal Dominant, with Severe Exacerbation in Pregnancy:

# Genetic test Affiliating Genes
1 Hypertension, Early-Onset, Autosomal Dominant, with Severe Exacerbation in Pregnancy 29 NR3C2

Anatomical Context for Hypertension, Early-Onset, Autosomal Dominant, with Severe...

MalaCards organs/tissues related to Hypertension, Early-Onset, Autosomal Dominant, with Severe Exacerbation in Pregnancy:

40
Heart, Kidney, Endothelial, Testes, Brain, Liver, Placenta

Publications for Hypertension, Early-Onset, Autosomal Dominant, with Severe...

Articles related to Hypertension, Early-Onset, Autosomal Dominant, with Severe Exacerbation in Pregnancy:

(showing 2566, show less)
# Title Authors PMID Year
1
Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. 56 6
10884226 2000
2
Neonatal Seizures Among Low-Risk Pregnancies at Term: Risk Factors and Adverse Outcomes. 61
32459434 2020
3
Characteristics and preventability of obstetric intensive care unit admissions in Far North Queensland. 61
32557552 2020
4
Blood-brain barrier dysfunction: the undervalued frontier of hypertension. 61
32424144 2020
5
Early gestational diabetes screening in obese women: a randomized controlled trial. 61
31926951 2020
6
Placental Overexpression of Soluble CORIN in Preeclampsia. 61
32084366 2020
7
Caesarean birth by maternal request: a poorly understood phenomenon in low- and middle-income countries. 61
32478383 2020
8
The predictive capacity of uterine artery Doppler for preterm birth-A cohort study. 61
31715024 2020
9
Developing and applying a costing tool for hypertension and related cardiovascular disease: Attributable costs to salt/sodium consumption. 61
32108425 2020
10
The WNK signaling pathway and salt-sensitive hypertension. 61
32286498 2020
11
Society for Maternal-Fetal Medicine (SMFM) Consult Series #50: The role of activity restriction in obstetric management. 61
32360110 2020
12
Notch3 in Development, Health and Disease. 61
32210034 2020
13
Twins versus singleton pregnancies: outcomes in small for gestational age late preterm deliveries. 61
30078342 2020
14
Development of a prediction model to target screening for high blood pressure in children. 61
31981642 2020
15
 Comparison and evaluation of Abbott chemiluminescent microparticle immunoassay and ChIVD light-initiated chemiluminescent assay in the detection of Treponema pallidum antibody. 61
32133697 2020
16
Associating 197 Chinese herbal medicine with drug targets and diseases using the similarity ensemble approach. 61
31530902 2020
17
Alterations on a key nephrogenic/cardiogenic gene expression linked to hypertension development. 61
31472952 2020
18
Laparoscopic mini/one anastomosis gastric bypass: anatomic features, imaging, efficacy and postoperative complications. 61
32189194 2020
19
Cost Effectiveness of Antenatal Lifestyle Interventions for Preventing Gestational Diabetes and Hypertensive Disease in Pregnancy. 61
32026397 2020
20
Does the AQHI reduce cardiovascular hospitalization in Hong Kong's elderly population? 61
31801101 2020
21
The association between high particulate matter pollution and daily cause-specific hospital admissions: a time-series study in Yichang, China. 61
31848968 2020
22
Harmonising research outcomes for polycystic ovary syndrome: an international multi-stakeholder core outcome set. 61
32020203 2020
23
Cardiovascular Function in Obstructive Sleep Apnea Patients with Controlled Hypertension. 61
32026418 2020
24
Early Onset Severe Hypertensive Disease in Pregnancy and Screening for Antiphospholipid Syndrome. 61
32140289 2020
25
Risks of cause-specific mortality in offspring of pregnancies complicated by hypertensive disease of pregnancy. 61
31336073 2020
26
Central hemodynamics are associated with fetal outcomes in pregnancies of advanced maternal age. 61
31923879 2020
27
Sleep-disordered breathing does not impact maternal outcomes in women with hypertensive disorders of pregnancy. 61
32339208 2020
28
Initial-onset symptoms of preeclampsia and their relation to pregnancy outcomes. 61
31790312 2019
29
Association of Cardiovascular Disease With Premature Mortality in the United States. 61
31617863 2019
30
Maternal diabetes during pregnancy and early onset of cardiovascular disease in offspring: population based cohort study with 40 years of follow-up. 61
31801789 2019
31
Urban-rural comparisons in health risk factor, health status and outcomes in Tianjin, China: A cross-sectional survey (2009-2013). 61
31614059 2019
32
Prevalence and determinants of stillbirth in Nigerian referral hospitals: a multicentre study. 61
31888536 2019
33
Cardiovascular Disease and hospital admissions in African immigrants and former Soviet Union immigrants: A retrospective cohort study. 61
31477314 2019
34
Comparison of four prognostic scales for predicting mortality in patients with severe maternal morbidity. 61
31810578 2019
35
[The remote results of treatment of ischemic stroke conditioned by atherosclerotic affection of carotid arteries]. 61
31884766 2019
36
The Steroid Profile of Adrenal Incidentalomas: Subtyping Subjects With High Cardiovascular Risk. 61
31381072 2019
37
Dysregulated expression of ACTN4 contributes to endothelial cell injury via the activation of the p38-MAPK/p53 apoptosis pathway in preeclampsia. 61
31399951 2019
38
Placental bed research: I. The placental bed: from spiral arteries remodeling to the great obstetrical syndromes. 61
31163132 2019
39
Impact of Perinatal Different Intrauterine Environments on Child Growth and Development: Planning and Baseline Data for a Cohort Study. 61
31714249 2019
40
Genetically determined serum urate levels and cardiovascular and other diseases in UK Biobank cohort: A phenome-wide mendelian randomization study. 61
31626644 2019
41
Nitric Oxide in the Prevention of Pre-eclampsia (NOPE): A Double-Blind Randomized Placebo-Controlled Trial Assessing the Efficacy of Isosorbide Mononitrate in the Prevention of Pre-eclampsia in High-Risk Women. 61
31686742 2019
42
A new customised placental weight standard redefines the relationship between maternal obesity and extremes of placental size and is more closely associated with pregnancy complications than an existing population standard. 61
31587680 2019
43
Obstetric Complications of Donor Egg Conception Pregnancies. 61
31598040 2019
44
Peripartum Cardiomyopathy: A Review. 61
31534832 2019
45
Influence of intrauterine growth restriction on caesarean delivery risk among preterm pregnancies undergoing induction of labor for hypertensive disease. 61
31290217 2019
46
SAFE@HOME - Feasibility study of a telemonitoring platform combining blood pressure and preeclampsia symptoms in pregnancy care. 61
31330428 2019
47
A National Dataset Analysis of older adults in emergency department observation units. 61
30563716 2019
48
[Maternal deaths in Sweden: Diagnostics and clinical management could be improved]. 61
31573669 2019
49
[Participation of Sphingolipids in the Pathogenesis of Atherosclerosis]. 61
31397233 2019
50
Telemonitoring for hypertensive disease in pregnancy. 61
31282755 2019
51
Cardiac output measurements during high-risk Cesarean section using electrical bioreactance or arterial waveform analysis: assessment of agreement. 61
30302868 2019
52
A Comparative Study on the Memory-Enhancing Actions of Oral Renin-Angiotensin System Altering Drugs in Scopolamine-Treated Mice. 61
31106575 2019
53
Wave reflection in an anatomical model of the pulmonary circulation in local and global hypertensive disease. 61
31946976 2019
54
Relating the number of human leucocytes antigen mismatches to pregnancy complications in oocyte donation pregnancies: study protocol for a prospective multicentre cohort study (DONOR study). 61
31345965 2019
55
Right ventricular dysfunction in arterial hypertension: still terra incognita? 61
31076653 2019
56
Professional Driver's Job Stress and 8-year Risk of Cardiovascular Disease: The Taiwan Bus Driver Cohort Study. 61
31181005 2019
57
Transfer Entropy in Artificial and Cardiovascular Environment in Stress. 61
31945998 2019
58
Pattern of cardiac remodelling of the left ventricle in patients with essential hypertensive disease and concomitant type 2 diabetes mellitus. 61
31345920 2019
59
The immature platelet fraction in hypertensive disease during pregnancy. 61
30810879 2019
60
In-utero and perinatal influences on suicide risk: a systematic review and meta-analysis. 61
31029623 2019
61
ATP release drives heightened immune responses associated with hypertension. 61
31253642 2019
62
Effects of context-aware patient guidance on blood pressure self-measurement adherence levels. 61
28701078 2019
63
The differences in brain stem transcriptional profiling in hypertensive ISIAH and normotensive WAG rats. 61
32039698 2019
64
Surgical outcome in aortopulmonary window beyond the neonatal period. 61
30900319 2019
65
Interfacility Transport of the Pregnant Patient: A 5-year Retrospective Review of a Single Critical Care Transport Program. 61
30188241 2019
66
The placental bed vascular pathology revisited: a risk indicator for cardiovascular disease. 61
29172831 2019
67
Correlates of neutrophil/lymphocyte, platelet/lymphocyte, and platelet/neutrophil ratios of neonates of women with hypertensive disease of pregnancy with neonatal birth outcomes. 61
30835575 2019
68
Hypertensive Diseases of Pregnancy Increase Risk of Readmission With Heart Failure: A National Readmissions Database Study. 61
30577972 2019
69
Low fetal fraction of cell-free DNA predicts placental dysfunction and hypertensive disease in pregnancy. 61
31056151 2019
70
Delivery or expectant management for prevention of adverse maternal and neonatal outcomes in hypertensive disorders of pregnancy: an individual participant data meta-analysis. 61
30697855 2019
71
Potential Protective Role of Blood Pressure-Lowering Drugs on the Balance between Hemostasis and Fibrinolysis in Hypertensive Patients at Rest and During Exercise. 61
30714087 2019
72
Socioeconomic factors and mortality due to cerebrovascular and hypertensive disease in Brazil. 61
31028004 2019
73
Clinical efficacy of acute respiratory viral infections prevention in patients with chronic heart failure. 61
31094457 2019
74
Management of Hypertension in the Obese Pregnant Patient. 61
30915600 2019
75
Prevalence of colonisation by group B streptococcus in pregnant patients in Taguatinga, Federal District, Brazil: a cross-sectional study. 61
30656444 2019
76
Gestational hypertensive disorders show unique patterns of circulatory deterioration with ongoing pregnancy. 61
30673301 2019
77
Association between endoglin/transforming growth factor beta receptors 1, 2 gene polymorphisms and the level of soluble endoglin with preeclampsia in Egyptian women. 61
30496724 2019
78
Placental growth factor as an indicator of fetal growth restriction in late-onset small-for-gestational age pregnancies. 61
29851029 2019
79
Study on the association of hypertriglyceridemia with hypertensive states of pregnancy. 61
31638606 2019
80
[Estudio sobre la asociación de hipertrigliceridemia con los estados hipertensivos del embarazo]. 61
31182871 2019
81
The Evaluation of a 19-Year-Old With Hypertension and Proteinuria: A Case Report. 61
31064291 2019
82
Hypertensive ocular disease in cats: A guide to fundic lesions to facilitate early diagnosis. 61
30763152 2019
83
[A clinical and genetic analysis of risk factors for the development of acute and chronic cerebral ischemia]. 61
31184626 2019
84
Advanced maternal age and factors associated with neonatal near miss in nulliparous and multiparous women. 61
31800791 2019
85
Epidemiology of artherial hypertension in pregnants. 61
31664330 2019
86
Validation of the iHealth Track and Omron HEM-9210T automated blood pressure devices for use in pregnancy. 61
30825925 2019
87
Maternal and perinatal outcomes after elective induction of labor at 39 weeks in uncomplicated singleton pregnancy: a meta-analysis. 61
30298532 2019
88
GENDER DISPARITIES OF CIRCULATORY DISEASE PROGRESS IN THE CHORNOBYL ACCIDENT CLEAN-UP WORKERS AND PHOSPHODIESTERASE 4D GENE rs966221 POLYMORPHISM. 61
30582852 2018
89
Aldosterone and 18-Oxocortisol Coaccumulation in Aldosterone-Producing Lesions. 61
30571232 2018
90
Decreased KLHL3 expression is involved in the pathogenesis of pseudohypoaldosteronism type II caused by cullin 3 mutation in vivo. 61
29869755 2018
91
Erythrocyte heme‑oxygenation status indicated as a risk factor in prehypertension by Raman spectroscopy. 61
30251685 2018
92
Dynamic prediction of childhood high blood pressure in a population-based birth cohort: a model development study. 61
30467134 2018
93
Influence of Time Interval from Bariatric Surgery to Conception on Pregnancy and Perinatal Outcomes. 61
30027331 2018
94
Prospective observational study to determine the accuracy of first-trimester serum biomarkers and uterine artery Dopplers in combination with maternal characteristics and arteriography for the prediction of women at risk of preeclampsia and other adverse pregnancy outcomes. 61
28714317 2018
95
PATHOGENETIC LINKS OF THE COMBINED COURSE OF CHRONIC PANCREATITIS AND HYPERTENSIVE DISEASE AND THEIR ROLE IN THE FORMATION OF COMPLICATIONS. 61
30516499 2018
96
Hypertensive organ damage predicts future cognitive performance: A 9-year follow-up study in patients with hypertension. 61
30277642 2018
97
Economic Crisis and Amenable Mortality in Spain. 61
30347682 2018
98
Association Between Gestational Weight Gain and Perinatal Outcomes. 61
30204701 2018
99
Characteristics and severity of preeclampsia in young and elderly gravidas with hypertensive disease. 61
29935482 2018
100
[Clinicopathologic features of glomus tumor of the kidney]. 61
30107661 2018
101
Cellular and subcellular localization of uncoupling protein 2 in the human kidney. 61
29936692 2018
102
Long-term mortality risk and life expectancy following recurrent hypertensive disease of pregnancy. 61
29630888 2018
103
MR-PheWAS: exploring the causal effect of SUA level on multiple disease outcomes by using genetic instruments in UK Biobank. 61
29437585 2018
104
Chronic Thromboembolic Pulmonary Hypertension. 61
29966632 2018
105
The Relationship between Body Mass Index in Pregnancy and Adverse Maternal, Perinatal, and Neonatal Outcomes in Rural India and Pakistan. 61
29365329 2018
106
Trend and Causes of Maternal Mortality in a Nigerian Tertiary Hospital: A 5-year Retrospective Study (2010-2014) at the University of Calabar Teaching Hospital, Calabar, Nigeria. 61
29983819 2018
107
[Structural and Functional Characteristics of the Heart in Patients With "Constrictive", "Pseudo-Normal" and "Restrictive" Types of the Left Ventricular Diastolic Dysfunction]. 61
30362432 2018
108
Mortality causes and trends associated with giant cell arteritis: analysis of the French national death certificate database (1980-2011). 61
29554340 2018
109
Preeclampsia induced by STOX1 overexpression in mice induces intrauterine growth restriction, abnormal ultrasonography and BOLD MRI signatures. 61
29465714 2018
110
Stress, Genes, and Hypertension. Contribution of the ISIAH Rat Strain Study. 61
29909475 2018
111
A multicentre, cross-sectional study investigating the prevalence of hypertensive disease in patients presenting for elective surgery in the Western Cape Province, South Africa. 61
30004348 2018
112
"Hearts that strain": Distinguishing athlete's heart from hypertensive disease in the echo lab and beyond. 61
29964160 2018
113
Celecoxib restores angiogenic factor expression at the maternal-fetal interface in the BPH/5 mouse model of preeclampsia. 61
29521599 2018
114
Metabolic disorders during pregnancy and postpartum cardiometabolic risk. 61
29712720 2018
115
Gadd45a knockdown alleviates oxidative stress through suppressing the p38 MAPK signaling pathway in the pathogenesis of preeclampsia. 61
29908638 2018
116
Effects of excess thromboxane A2 on placental development and nutrient transporters in a Mus musculus model of fetal growth restriction. 61
29351577 2018
117
Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies. 61
29676281 2018
118
Multilevel convergence of interoceptive impairments in hypertension: New evidence of disrupted body-brain interactions. 61
29271093 2018
119
Associations of neighbourhood crime with adverse pregnancy outcomes among women in Chicago: analysis of electronic health records from 2009 to 2013. 61
29305526 2018
120
[Epigenetic Mechanisms of Blood-Pressure Regulation]. 61
29695687 2018
121
Authors reply re: Clinical follow up of women after hypertensive disease in pregnancy. 61
28994513 2018
122
The videolaryngoscope as a first-line intubation device in women with hypertensive disease of pregnancy. 61
28801160 2018
123
Incidence, aetiology and outcomes of obstetric-related acute kidney injury in Malawi: a prospective observational study. 61
29394890 2018
124
Racial Disparities in Adverse Pregnancy Outcomes and Psychosocial Stress. 61
29324613 2018
125
In reply to: Salman MM, Goetze N, Badrinath M, Shah M. The videolaryngoscope as a first-line intubation device in women with hypertensive disease of pregnancy. International Journal of Obstetric Anesthesia 2017;33. doi: http://dx.doi.org/10.1016/j.ijoa.2017.07.005. 61
29128165 2018
126
Re: Clinical follow up of women after hypertensive disease in pregnancy and Moderately elevated blood pressure during pregnancy and odds of hypertension later in life: the POUCHmoms longitudinal study Potential mechanisms for pregnant and, nonpregnant hypertension. 61
29024449 2018
127
[Hospitalizations due to complications of pregnancy and maternal and perinatal outcomes in a cohort of pregnant women in the Brazilian Unified National Health System in São Paulo, Brazil]. 61
29412326 2018
128
[Disability of elderly people due to hypertensive disease in the Russian Federation.] 61
29860726 2018
129
Management of Severe Pulmonary Hypertensive Disease for Surgical and Nonsurgical Procedures. 61
30204604 2018
130
[Lifespan of patients after endured embolism of the aorta and major arteries of the limbs]. 61
30321143 2018
131
Impact of renal denervation on tissue Na+ content in treatment-resistant hypertension. 61
28845508 2018
132
Qualitative and Quantitative Evaluation of Structural Myocardial Alterations by Grating-Based Phase-Contrast Computed Tomography. 61
28846552 2018
133
Kv7(KCNQ)-K+-Channels Influence Total Peripheral Resistance in Female but Not Male Rats, and Hamper Catecholamine Release in Hypertensive Rats of Both Sexes. 61
29515459 2018
134
Longevity and cardiovascular mortality of Polish elite football players. 61
30091130 2018
135
Epidemiology of Comorbid Conditions Among Adults 50 Years and Older With Traumatic Brain Injury. 61
28060201 2018
136
Preeclampsia: Acute Complications and Management Priorities. 61
30185498 2018
137
The Association between Dietary Vitamin C/E and Gestational Hypertensive Disorder: A Case-Control Study. 61
30606968 2018
138
Immune regulation of systemic hypertension, pulmonary arterial hypertension, and preeclampsia: shared disease mechanisms and translational opportunities. 61
28978513 2017
139
Hypertension Survey in Italy: Novel Findings from the Campania Salute Network. 61
28669066 2017
140
Quality of antenatal care service provision in health facilities across sub-Saharan Africa: Evidence from nationally representative health facility assessments. 61
29163936 2017
141
Longitudinal changes and correlations of bioimpedance and anthropometric measurements in pregnancy: Simple possible bed-side tools to assess pregnancy evolution. 61
27892802 2017
142
CHARACTERISTICS OF CHANGES IN COGNITIVE FUNCTIONS OF THE PATIENTS WITH HYPERTENSIVE DISEASE. 61
29227264 2017
143
[Analysis of Urine Proteome in Patients With Postinfarction Cardiosclerosis Combined With Hypertensive Disease for Assessing Endothelial Dysfunction]. 61
29276918 2017
144
Epidemiology of hypertension in Northern Tanzania: a community-based mixed-methods study. 61
29127232 2017
145
Association of Panic Disorder, Generalized Anxiety Disorder, and Benzodiazepine Treatment During Pregnancy With Risk of Adverse Birth Outcomes. 61
28903165 2017
146
The emerging challenge of optimal blood pressure management and hypertensive syndromes in pregnant women with sickle cell disease: a review. 61
28905692 2017
147
Genome-wide discovery of long intergenic noncoding RNAs and their epigenetic signatures in the rat. 61
29093522 2017
148
2017 Guidelines for the management of arterial hypertension in primary health care in Portuguese-speaking countries. 61
29162357 2017
149
'The obesity paradox': a reconsideration of obesity and the risk of preterm birth. 61
28749482 2017
150
Prevention of Cardiovascular Disease in Women. 61
29744010 2017
151
Clinical follow-up of women after hypertensive disease in pregnancy. 61
28440905 2017
152
Association Between Type of Screening for Gestational Diabetes Mellitus and Cesarean Delivery. 61
28796680 2017
153
Low Soluble Fms-Like Tyrosine Kinase-1, Endoglin, and Endothelin-1 Levels in Women With Confirmed or Suspected Preeclampsia Using Proton Pump Inhibitors. 61
28716993 2017
154
Influences of placental growth factor on mouse retinal vascular development. 61
28646507 2017
155
Sonographically abnormal placenta: an association with an increased risk poor pregnancy outcomes. 61
29044348 2017
156
Preeclampsia. 61
28793357 2017
157
Challenges in the diagnosis and management of anti-phospholipid syndrome: a case from Cameroon. 61
28789672 2017
158
Hypertension and Male Fertility. 61
28868816 2017
159
Endoplasmic reticulum stress in the pathogenesis of hypertension. 61
28605068 2017
160
Wnt/β-catenin signaling pathway in trophoblasts and abnormal activation in preeclampsia (Review). 61
29067442 2017
161
[Pathoanatomical and clinical aspects of the placenta in preterm birth]. 61
27255227 2017
162
Elevated Adenosine Induces Placental DNA Hypomethylation Independent of A2B Receptor Signaling in Preeclampsia. 61
28507174 2017
163
The effect of maternal age on fetal and neonatal mortality. 61
28358383 2017
164
Iodine levels are associated with oxidative stress and antioxidant status in pregnant women with hypertensive disease 61
28627204 2017
165
Long-term consequences of obesity on female fertility and the health of the offspring. 61
28448277 2017
166
Stress-sensitive arterial hypertension, haemodynamic changes and brain metabolites in hypertensive ISIAH rats: MRI investigation. 61
28273684 2017
167
Outcomes of Twin Pregnancies in Women 45 Years of Age or Older. 61
28383389 2017
168
Impaired degradation of medullary WNK4 in the kidneys of KLHL2 knockout mice. 61
28414128 2017
169
Microvascular structure as a prognostically relevant endpoint. 61
28355167 2017
170
[Clinical study of application minimally invasive expandable channel in lumbar discectomy and interbody fusion and internal fixation]. 61
29417768 2017
171
Risk Factors and Incidence of Puerperal Genital Haematomas. 61
28658851 2017
172
Plasma N-Terminal Probrain Natriuretic Peptide, Vascular Endothelial Growth Factor, and Cardiac Troponin I as Novel Biomarkers of Hypertensive Disease and Target Organ Damage in Cats. 61
28387019 2017
173
[Changes of Concentration of Irisin in Blood of Patients With Hypertensive Disease After Physical Effort]. 61
28762909 2017
174
Patterns of Blood Pressure and Stress: A Descriptive Report among Anesthesiology Residents Institution. 61
28824934 2017
175
Toward Gene Therapy of Hypertension: Experimental Study on Hypertensive ISIAH Rats. 61
28371602 2017
176
Obstetric Disorders in the ICU. 61
28561253 2017
177
Maternal hypertensive disorders are associated with increased use of respiratory support but not chronic lung disease or poorer neurodevelopmental outcomes in preterm neonates at <29 weeks of gestation. 61
28121046 2017
178
Hypertensive disorders in pregnancy and later dementia: a Swedish National Register Study. 61
28094840 2017
179
Guidelines of the French Society of Otorhinolaryngology (SFORL). Epistaxis and high blood pressure. 61
27726975 2017
180
[Endothelial immune activation and functional state in patients with hypertensive disease]. 61
29039826 2017
181
[The influence of Cytoflavin therapy on the cerebral hemodynamics in patients with various stages of hypertensive disease]. 61
28805757 2017
182
Obesity: A Perspective from Hypertension. 61
27884225 2017
183
[Pathogenesis of myocarditis in patients with bronchial asthma and pecilomycosis]. 61
30299069 2017
184
[Regulatory adaptive status in determining the effectiveness of bisoprololum and sotalolum in patients with hypertensive disease and paroxysmal supraventricular tachycardia]. 61
29276907 2017
185
Unexpected sudden death in pregnancy - arrhythmogenic right ventricular cardiomyopathy/dysplasia: a case report. 61
30483636 2017
186
Surge of immune cell formation at birth differs by mode of delivery and infant characteristics-A population-based cohort study. 61
28910364 2017
187
Weight change across the start of three consecutive pregnancies and the risk of maternal morbidity and SGA birth at the second and third pregnancy. 61
28628636 2017
188
Micro- and Nano-vesicles from First Trimester Human Placentae Carry Flt-1 and Levels Are Increased in Severe Preeclampsia. 61
28790977 2017
189
Planned early delivery versus expectant management for hypertensive disorders from 34 weeks gestation to term. 61
28106904 2017
190
Maternal and neonatal outcomes in pregnancy induced hypertension: an observational study. 61
29714877 2017
191
[Chronic constipation in the practice of a therapist: Features of therapy for comorbidity]. 61
28514403 2017
192
Utility of overnight pulse oximeter as a screening tool for sleep apnea to assess the 8-year risk of cardiovascular disease: Data from a large-scale bus driver cohort study. 61
27728865 2016
193
All-Cause and Cause-Specific Mortality After Hypertensive Disease of Pregnancy. 61
27875458 2016
194
Renal Interlobar Vein Impedance Index as a First-Trimester Marker Does Not Predict Hypertensive Disorders of Pregnancy. 61
27821655 2016
195
Molecular determinants of the adrenal gland functioning related to stress-sensitive hypertension in ISIAH rats. 61
28105924 2016
196
[Comparison of Verapamil and Amlodipine for Treatment of Chronic Heart Failure With Preserved Left Ventricular Ejection Fraction in Patients With Hypertensive Disease]. 61
28290801 2016
197
Intensive Hemodialysis, Left Ventricular Hypertrophy, and Cardiovascular Disease. 61
27772643 2016
198
Uterine artery pulsatility index in hypertensive pregnancies: When does the index normalize in the puerperium? 61
27896248 2016
199
Obstetric predictors of hypertension: A cross-sectional study of women attending the postnatal clinic of Jos University Teaching Hospital. 61
27942098 2016
200
Gestational hypertensive disease in twin pregnancy: Influence on outcomes in a large national prospective cohort. 61
27302243 2016
201
Hypertensive disease in pregnancy in Botswana: Prevalence and impact on perinatal outcomes. 61
27939493 2016
202
Impact of performance grading on annual numbers of acute myocardial infarction-associated emergency department visits in Taiwan: Results of segmented regression analysis. 61
27759626 2016
203
Indications for primary cesarean delivery relative to body mass index. 61
27210064 2016
204
A prediction model of vaginal birth after cesarean in the preterm period. 61
27262971 2016
205
[Risk factors for cardiovascular disease in patients with hypertensive disorders during pregnancy. Experience of 10 years]. 61
29424978 2016
206
[Psychological Characteristics of Patients With Stress-induced Arterial Hypertension: a Violation of the Regulation of Emotions as a Central Link of Pathogenesis]. 61
28290863 2016
207
Long-Term Mortality After Hypertensive Disease of Pregnancy. 61
27399993 2016
208
All-Cause and Cause-Specific Mortality After Hypertensive Disease of Pregnancy. 61
27400006 2016
209
Current Concepts of Maternal Nutrition. 61
27436176 2016
210
Caesarean section rates and adverse neonatal outcomes after induction of labour versus expectant management in women with an unripe cervix: a secondary analysis of the HYPITAT and DIGITAT trials. 61
27173131 2016
211
Drinking Water Sodium and Elevated Blood Pressure of Healthy Pregnant Women in Salinity-Affected Coastal Areas. 61
27297000 2016
212
A case of hypertensive urgency. 61
26002343 2016
213
Cloud-based BP system integrated with CPOE improves self-management of the hypertensive patients: A randomized controlled trial. 61
27282232 2016
214
Trends in Congenital Heart Defects in Infants With Down Syndrome. 61
27252035 2016
215
Sodium nitrite attenuates hypertension-in-pregnancy and blunts increases in soluble fms-like tyrosine kinase-1 and in vascular endothelial growth factor. 61
27181106 2016
216
THE ROLE OF POLYMORPHISM - 634 G/C (RS 2010963) OF VEGF-A GENE IN THE DEVELOPMENT OF HYPERTENSION AND OBESITY IN PREMENOPAUSAL WOMEN. 61
27661273 2016
217
Exhaustive Genome-Wide Search for SNP-SNP Interactions Across 10 Human Diseases. 61
27185397 2016
218
[Pathophysiology of preeclampsia]. 61
27217262 2016
219
[Medical approaches for managing preeclampsia]. 61
27234904 2016
220
Evaluation of the impact on non-communicable chronic diseases of a major integrated primary health care program in Mexico. 61
26094115 2016
221
The patient with hypertension undergoing surgery. 61
27031792 2016
222
Evidence for a critical role of the sympathetic nervous system in hypertension. 61
27052349 2016
223
Spatial analysis of the regional variation of hypertensive disease mortality and its socio-economic correlates in South Korea. 61
27245801 2016
224
County Health Factors Associated with Avoidable Deaths from Cardiovascular Disease in the United States, 2006-2010. 61
27252564 2016
225
Network for Surveillance of Severe Maternal Morbidity: a powerful national collaboration generating data on maternal health outcomes and care. 61
26412586 2016
226
Red cell distribution width and end-organ damage in patients with systo-diastolic hypertension. 61
27186175 2016
227
Reduced spontaneous platelet aggregation: a novel risk factor for adverse pregnancy outcome. 61
26927895 2016
228
Variation in primary cesarean delivery rates by individual physician within a single-hospital laborist model. 61
26922481 2016
229
The Prognostic Role of Angiotensin II Type 1 Receptor Autoantibody in Non-Gravid Hypertension and Pre-eclampsia: A Meta-analysis and Our Studies. 61
27124051 2016
230
[Obstetrical complications of thyroid peroxidase antibody positive during pregnancy and effects of intervention: a meta-analysis]. 61
27116982 2016
231
Hypertension in the Emergency Department. 61
27072830 2016
232
The Post-Anesthetic Care of Pediatric Patients With Pulmonary Hypertension. 61
26134177 2016
233
Meandering right pulmonary vein associated with severe and progressive "idiopathic-like" pulmonary hypertensive vascular disease. 61
26374461 2016
234
[Effect of Combined Antihypertensive Therapy With Perindopril and Indapamide on Morpho-Functional Parameters of The Heart, Blood Vessels of Small and Medium Caliber in Patients With Essential Hypertension]. 61
28294884 2016
235
Potential Role of Placental Klotho in the Pathogenesis of Preeclampsia. 61
26972301 2016
236
Hypertensive disorders of pregnancy: what the physician needs to know. 61
27213858 2016
237
Medical disease as a cause of maternal mortality: the pre-imminence of cardiovascular pathology. 61
27213855 2016
238
Quality of life in patients with nonalcoholic fatty liver disease in combination with essential hypertension considering taste sensitivity to sodium chloride. 61
27487534 2016
239
Pregnancy hypertensive disease and risk of dementia and cardiovascular disease in women aged 65 years or older: a cohort study. 61
26801467 2016
240
Stress and hypertensive disease: adrenals as a link. Experimental study on hypertensive ISIAH rat strain. 61
27362777 2016
241
[Effect of cytoflavin on the clinical and autonomic-psychological manifestations of hypertensive disease]. 61
27239928 2016
242
[THE INFLUENCE OF MELATONIN ON THE PARAMETERS OF CEREBRAL HEMODYNAMICS IN PATIENTS WITH HYPERTENSIVE DISEASE]. 61
27172718 2016
243
[THE PROGRAM OF PHYSICAL REHABILITATION FOR PATIENTS WITH CORONARY HEART DISEASE AND HYPERTENSIVE DISEASE]. 61
27172720 2016
244
T-regulatory cells and vascular function: the importance of their immunosuppressive action in hypertensive disease. 61
26630210 2016
245
Annual incidence of mortality related to hypertensive disease in Canada and associations with heliophysical parameters. 61
25913078 2016
246
Reducing the risk of fetal distress with sildenafil study (RIDSTRESS): a double-blind randomised control trial. 61
26767411 2016
247
Maternal abdominal subcutaneous fat thickness as a predictor for adverse pregnancy outcome: a longitudinal cohort study. 61
26840907 2016
248
Early cardiovascular events in women with a history of gestational diabetes mellitus. 61
26817691 2016
249
[The stages of development of cardiovascular diseases and the evolution of their pattern in the veterans of the Great Patriotic War (according to the 1946-2015 records of the Saint Petersburg War Veterans Hospital)]. 61
26978604 2016
250
Novel indexes of arrhythmogenesis in preeclampsia: QT dispersion, Tp-e interval, and Tp-e/QT ratio. 61
26955770 2016
251
[HYPERTENSIVE CRISIS: MODERN VIEW OF THE PROBLEM AND OPTIMIZATION OF DIAGNOSTIC AND THERAPEUTIC MODALITIES]. 61
27172724 2016
252
Modeling Disease Progression: Angiotensin II Indirectly Inhibits Nitric Oxide Production via ADMA Accumulation in Spontaneously Hypertensive Rats. 61
27909412 2016
253
[Regulatory Adaptive Status in Assessment of Efficacy of Pharmacotherapy and Prognostication of Complications in Functional Class III Chronic Heart Failure]. 61
28294725 2016
254
[Arterial hypertension as a risk factor of intra-atrial thrombosis in patients with atrial fibrillation of non-valvular etiology]. 61
30289660 2016
255
[C-REACTIVE PROTEIN AS AN INDICATOR OF RISK OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND ITS CORRECTION]. 61
30296044 2016
256
Association between the growth arrest-specific 6 (Gas6) gene polymorphism c.834 + 7G>A and preeclampsia. 61
25915719 2016
257
Morphological changes of placental syncytium and their implications for the pathogenesis of preeclampsia. 61
26496726 2016
258
Perirenal Edema as a potential hint towards primary hypertension-Preliminary findings in MRI breast cancer staging. 61
27331084 2016
259
[Septic shock in pregnancy on the basis of an acute pyelonephritis]. 61
27882751 2016
260
What Clinical Interventions Have Been Implemented to Prevent or Reduce Postpartum Hypertension Readmissions? A Clin-IQ. 61
27695701 2016
261
[HOMOCYSTEINE AS A PROGNOSTIC MARKER OF ATRIAL REMODELING AND CLINICAL PICTURE IN PATIENTS WITH PAROXYSMAL AND PERSISTENT FORMS OF ATRIAL FIBRILLATION]. 61
27172716 2016
262
[PHARMACOLOGICAL CORRECTION OF RED BLOOD CELL MEMBRANE LIPID SPECTRUM IN PATIENTS WITH CHRONIC CEREBRAL ISCHEMIA ON THE BACKGROUND OF HYPERTENSIVE DISEASE.] 61
29782737 2016
263
The Association of Family History of Premature Cardiovascular Disease or Diabetes Mellitus on the Occurrence of Gestational Hypertensive Disease and Diabetes. 61
27918585 2016
264
In-Depth N-Glycosylation Reveals Species-Specific Modifications and Functions of the Royal Jelly Protein from Western (Apis mellifera) and Eastern Honeybees (Apis cerana). 61
26496797 2015
265
Burden attributable to Cardiometabolic Diseases in Zimbabwe: a retrospective cross-sectional study of national mortality data. 61
26644134 2015
266
Posterior communicating and vertebral artery configuration and outcome in endovascular treatment of acute basilar artery occlusion. 61
25230838 2015
267
Effects of Extreme Temperatures on Cause-Specific Cardiovascular Mortality in China. 61
26703637 2015
268
Hypertensive disease of pregnancy in the ICU: a multicenter study. 61
25316558 2015
269
An Update on Inpatient Hypertension Management. 61
26362300 2015
270
No association between adherence to the healthy Nordic food index and cardiovascular disease amongst Swedish women: a cohort study. 61
25991078 2015
271
Impaired degradation of WNK by Akt and PKA phosphorylation of KLHL3. 61
26435498 2015
272
Involvement of selective autophagy mediated by p62/SQSTM1 in KLHL3-dependent WNK4 degradation. 61
26349538 2015
273
The Role of the (Pro)renin Receptor in Hypertensive Disease. 61
25890829 2015
274
[Bortezomib-induced peripheral neuropathy in multiple myeloma patients]. 61
26815352 2015
275
Cerebrovascular, cardiovascular and renal hypertensive disease after hypertensive disorders of pregnancy. 61
26597742 2015
276
Generation and analysis of knock-in mice carrying pseudohypoaldosteronism type II-causing mutations in the cullin 3 gene. 61
26490675 2015
277
IGF-1 signaling in neonatal hypoxia-induced pulmonary hypertension: Role of epigenetic regulation. 61
25921925 2015
278
Role of vascular endothelial growth factor and placental growth factor expression on placenta structure in pre-eclamptic pregnancy. 61
26177586 2015
279
Type-specific orthostatic hemodynamic response of hypertensive diseases in pregnancy. 61
26192080 2015
280
[Perioperative Management of Elderly Patients Over 90 Years of Age with Femoral Neck/Trochanteric Fracture]. 61
26742404 2015
281
Beat-to-beat heart rate and blood pressure variability and hypertensive disease in pregnancy. 61
25970272 2015
282
Retinal microperfusion after renal denervation in treatment-resistant hypertensive patients. 61
25916737 2015
283
Kelch-Like Protein 2 Mediates Angiotensin II-With No Lysine 3 Signaling in the Regulation of Vascular Tonus. 61
25556166 2015
284
Maternal near miss and mortality in a tertiary care hospital in Rwanda. 61
26334634 2015
285
Mode of anaesthesia for preterm Caesarean delivery: secondary analysis from the Maternal-Fetal Medicine Units Network Caesarean Registry. 61
25956901 2015
286
Risk of cardiovascular disease in HIV-positive Queensland men receiving combined antiretroviral therapy. 61
26028226 2015
287
[The modern applications of radon therapy for the medical rehabilitation of the patients]. 61
26595970 2015
288
Maternal risk factors for neonatal necrotizing enterocolitis. 61
25162307 2015
289
[Inequalities in mortality by cardiovascular diseases in the Colombian Coffee Growing Region, 2009-2011]. 61
26849700 2015
290
Echocardiographic and Hemodynamic Predictors of Survival in Precapillary Pulmonary Hypertension: Seven-Year Follow-Up. 61
26063743 2015
291
[Evolutionary and Genetic Roots of Hypertensive Disease]. 61
26310028 2015
292
Hypoxia-independent upregulation of placental hypoxia inducible factor-1α gene expression contributes to the pathogenesis of preeclampsia. 61
25847948 2015
293
A uniform management approach to optimize outcome in fetal growth restriction. 61
26002166 2015
294
Ultrasound entropy may be a new non-invasive measure of pre-clinical vascular damage in young hypertensive patients. 61
25888961 2015
295
Dietary contributors to hypertension in adults reviewed. 61
25150713 2015
296
Cardiovascular disease risk factors after early-onset preeclampsia, late-onset preeclampsia, and pregnancy-induced hypertension. 61
25561694 2015
297
Inflammation and congenital heart disease associated pulmonary hypertension. 61
25881225 2015
298
Small for gestational age births among South Indian women: temporal trend and risk factors from 1996 to 2010. 61
25645738 2015
299
Causes of perinatal mortality and associated maternal complications in a South African province: challenges in predicting poor outcomes. 61
25880128 2015
300
[Specific features of hypertension in patients with systemic lupus erythematosus]. 61
26087631 2015
301
[EVALUATION OF THE REGULATORY-ADAPTIVE STATUS FOR PROGNOSTICATION IN SYSTOLIC CHRONIC HEART FAILURE]. 61
26987135 2015
302
An update on renal artery denervation and its clinical impact on hypertensive disease. 61
26495305 2015
303
[Late cardiotoxicity of high-dose chemotherapy according to the modified NHL-BFM-90 program in adult patients with diffuse large B-cell lymphoma]. 61
26390725 2015
304
Hospitalization in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients. 61
25085647 2015
305
Global network for women's and children's health research: a system for low-resource areas to determine probable causes of stillbirth, neonatal, and maternal death. 61
27057328 2015
306
Relationship between semen production and medical comorbidity. 61
25497466 2015
307
Incident depression increases medical utilization in Medicaid patients with hypertension. 61
25487173 2015
308
Placental expression of miR-517a/b and miR-517c contributes to trophoblast dysfunction and preeclampsia. 61
25799546 2015
309
The effect of ozone on blood pressure in DOCA-salt-induced hypertensive rats. 61
26550192 2015
310
Induction of apoptosis by hypertension via endoplasmic reticulum stress. 61
25791362 2015
311
[SCLEROSIS: LOCAL AND GENERAL PATTERNS OF DEVELOPMENT]. 61
26669029 2015
312
[THE INFLUENCE OF ABDOMINAL OBESITY ON LEFT VENTRICULAR MYOCARDIALREMODELING IN PATIENTS WITH ARTERIAL HYPERTENSION]. 61
26596063 2015
313
[ARTERIAL HYPERTENSION: A MODERN VIEW OF THE PROBLEM]. 61
26669036 2015
314
Diuretics in the treatment of elderly hypertensive patients. 61
25761103 2015
315
Age at menarche and risks of coronary heart and other vascular diseases in a large UK cohort. 61
25512444 2015
316
Do uterine natural killer cell numbers in peri-implantation endometrium predict hypertensive disorder in pregnancy in women with a history of reproductive failure? 61
25023194 2014
317
Multi-label classification of chronically ill patients with bag of words and supervised dimensionality reduction algorithms. 61
24879897 2014
318
A retrospective analysis of obstetric patient's outcome in intensive care unit of a tertiary care center. 61
25425775 2014
319
Characteristics of obstetric patients referred to intensive care in an Australian tertiary hospital. 61
24738907 2014
320
Regulation of blood pressure and renal electrolyte balance by Cullin-RING ligases. 61
24992566 2014
321
Improved trabecular bone structure of 20-month-old male spontaneously hypertensive rats. 61
25106873 2014
322
Maternal preeclampsia and risk for cardiovascular disease in offspring. 61
25097112 2014
323
Placental pathology in early intrauterine growth restriction associated with maternal hypertension. 61
25052232 2014
324
The excess mortality related to cardiovascular diseases and cancer among adults pharmacologically treated for diabetes--the 2001-2006 ENTRED cohort. 61
24627972 2014
325
Bariatric metabolic surgery. 61
25230385 2014
326
Association between maternal characteristics, abnormal serum aneuploidy analytes, and placental abruption. 61
24631707 2014
327
Monitoring of non-communicable diseases such as hypertension in South Africa: challenges for the post-2015 global development agenda. 61
25363054 2014
328
Measuring the burden of disease due to climate change and developing a forecast model in South Korea. 61
25132390 2014
329
[Disability attributable to excess weight in Spain]. 61
23932567 2014
330
Diagnostic and predictive accuracy of placental growth factor in suspected pre-eclampsia. 61
26104637 2014
331
Maternal mortality in the United States: predictability and the impact of protocols on fatal postcesarean pulmonary embolism and hypertension-related intracranial hemorrhage. 61
24631705 2014
332
Young women's recent experience of labour and birth care in Queensland. 61
23916403 2014
333
Prediction of recurrence of hypertensive disorders of pregnancy in the term period, a retrospective cohort study. 61
26104605 2014
334
Predicting successful intended vaginal delivery after previous caesarean section: external validation of two predictive models in a Dutch nationwide registration-based cohort with a high intended vaginal delivery rate. 61
24533534 2014
335
Social obstetrics: non-local expectant mothers admitted through accident and emergency department in a public hospital in Hong Kong. 61
24812199 2014
336
WNK4 is the major WNK positively regulating NCC in the mouse kidney. 61
24655003 2014
337
The Clinical Features and Prognosis of Gastric Remnant Carcinoma after Treatment. 61
26176040 2014
338
Tuberculous abdominal aortic aneurysm with alimentary tract hemorrhage: a case report with medico-legal implications. 61
25073323 2014
339
Prevalence of asymptomatic bacteriuria and its antibacterial susceptibility pattern among pregnant women attending the antenatal clinic at kanpur, India. 61
24959438 2014
340
Cold-related cardiorespiratory symptoms among subjects with and without hypertension: the National FINRISK Study 2002. 61
23794677 2014
341
The role of L-arginine in the prevention and treatment of pre-eclampsia: a systematic review of randomised trials. 61
24172291 2014
342
Prehypertension and cardiovascular risk factors in children and adolescents participating in the community-based prevention education program family heart study. 61
24791192 2014
343
Fruits, vegetables, and hypertensive disease mortality. 61
24487224 2014
344
Regulation of with-no-lysine kinase signaling by Kelch-like proteins. 61
24313290 2014
345
[A fixed-dose lisinopril and amlodipine combination in conjunction with rosuvastatin in patients with hypertensive disease and coronary heart disease]. 61
25518509 2014
346
Dynamic blood flow and wall shear stress in pulmonary hypertensive disease. 61
25571282 2014
347
Racial/ethnic differences in pregnancy-related hypertensive disease in nulliparous women. 61
25065068 2014
348
[Biochemical markers of endothelial dysfunction in chronic obstructive pulmonary disease concurrent with hypertensive disease or coronary heart disease]. 61
24779065 2014
349
[Effectiveness of diagnostics and treatment of complicated hypertensive disease taking into account results of 3 day arterial pressure monitoring]. 61
25790709 2014
350
Relationship between resistant hypertension and arterial stiffness assessed by brachial-ankle pulse wave velocity in the older patient. 61
25228801 2014
351
[Prognostic value of detection of arterial hypotensive episodes in patients with chronic heart failure]. 61
24864461 2014
352
[Cystatin C and preclinical lesions in the target organs of hypertensive patients]. 61
25518503 2014
353
[Effect of loop diuretics with different elimination half-lives on natriuresis changes and indicators characterizing the state of renal tubulointerstitial tissue]. 61
25095654 2014
354
Quantifying proteinuria in hypertensive disorders of pregnancy. 61
25302114 2014
355
Telmisartan delays myocardial fibrosis in rats with hypertensive left ventricular hypertrophy by TGF-β1/Smad signal pathway. 61
24089264 2014
356
Pre-eclampsia and gestational hypertension are less common in HIV infected women. 61
26104261 2014
357
Acute postoperative cervical spinal epidural hematoma. 61
25230268 2014
358
[Maternal risk factors associated with the necessity of neonatal intensive care unit]. 61
24554227 2014
359
Decrease of risk of developing symptoms of OAB in elderly men and women treated with loop diuretic for hypertensive disease using solifenacin. 61
25495568 2014
360
Clinical evaluation of a first trimester algorithm predicting the risk of hypertensive disease of pregnancy. 61
23919594 2013
361
Periviable births: epidemiology and obstetrical antecedents. 61
24290393 2013
362
Antiphospholipid antibodies internalised by human syncytiotrophoblast cause aberrant cell death and the release of necrotic trophoblast debris. 61
24035196 2013
363
Mortality due to diseases of the circulatory system among the elderly population in Brazilian Amazon: temporal and spatial analysis. 61
24896589 2013
364
Severe pre-eclampsia and hypertensive crises. 61
23962474 2013
365
Impaired effect of relaxin on vasoconstrictor reactivity in spontaneous hypertensive rats. 61
24012667 2013
366
Differential treatment of hypertension by primary care providers and hypertension specialists in a barber-based intervention trial to control hypertension in Black men. 61
23978276 2013
367
Chemical library screening for WNK signalling inhibitors using fluorescence correlation spectroscopy. 61
23981180 2013
368
[The influence of carbon dioxide baths differing in the total mineralization levels on the functional state of the cardiovascular system of the patients presenting with hypertensive disease associated with coronary heart disease]. 61
24640650 2013
369
Endothelial caveolar subcellular domain regulation of endothelial nitric oxide synthase. 61
23745825 2013
370
[Changes in the functional state of the vascular endothelium in patients with hypertensive disease and heart valves calcification under influence of the lipid-lowering therapy]. 61
25509912 2013
371
Blood pressure homeostasis is maintained by a P311-TGF-β axis. 61
24091331 2013
372
Neurochemicals involved in medullary control of common carotid blood flow. 61
24403875 2013
373
Trends in the prevalence of hospitalization attributable to hypertensive diseases among United States adults aged 35 and older from 1980 to 2007. 61
23726180 2013
374
Erectile dysfunction and target organ damage in the early stages of hypertension. 61
24034657 2013
375
Vital signs: avoidable deaths from heart disease, stroke, and hypertensive disease - United States, 2001-2010. 61
24005227 2013
376
Early pregnancy circulatory adaptation and recurrent hypertensive disease: an explorative study. 61
23420822 2013
377
Smad7 inhibits angiotensin II-induced hypertensive cardiac remodelling. 61
23761400 2013
378
Improving antenatal prediction of small-for-gestational-age neonates by using customized versus population-based reference standards. 61
23980218 2013
379
Circulating biomarkers of collagen metabolism in arterial hypertension: relevance of target organ damage. 61
23615327 2013
380
Integrating the myocardial matrix into heart failure recognition and management. 61
23989715 2013
381
KLHL2 interacts with and ubiquitinates WNK kinases. 61
23838290 2013
382
Epidemiology of obstetric-related ICU admissions in Maryland: 1999-2008*. 61
23648568 2013
383
Dementia and lower blood pressure in Latin America, India, and China: a 10/66 cross-cohort study. 61
23771488 2013
384
MR relaxometry and perfusion of the myocardium in spontaneously hypertensive rat: correlation with histopathology and effect of anti-hypertensive therapy. 61
23591616 2013
385
[Endothelial dysfunction in pregnancies with chronic hypertension]. 61
23869827 2013
386
Assessment of Systolic and Diastolic Cardiac Function beyond Traditional Markers in Hypertensive Patients. Role of Cardiac Reserve. 61
24371488 2013
387
Maternal cardiovascular risk profile after placental abruption. 61
23529170 2013
388
Magnesium sulphate for prevention of eclampsia: are intramuscular and intravenous regimens equivalent? A population pharmacokinetic study. 61
23530757 2013
389
Hypertensive disease of pregnancy is associated with decreased risk for respiratory distress syndrome in moderate preterm neonates. 61
23725082 2013
390
Angiotensin II regulates microRNA-132/-212 in hypertensive rats and humans. 61
23712358 2013
391
A case of successful bare metal stenting for aortic coarctation in an adult. 61
23682288 2013
392
Hypertensive disease of pregnancy and maternal mortality. 61
23403779 2013
393
Thrombocytopenia in hypertensive disease of pregnancy. 61
24431613 2013
394
Independent risk factors for infants who are small for gestational age by customised birthweight centiles in a multi-ethnic New Zealand population. 61
23130970 2013
395
Prediction of 30-day cardiac-related-emergency-readmissions using simple administrative hospital data. 61
21775001 2013
396
Impaired KLHL3-mediated ubiquitination of WNK4 causes human hypertension. 61
23453970 2013
397
[24-hour monitoring central aortic pressure in patients with hypertensive disease and concomitant chronic obstructive pulmonary disease]. 61
24437169 2013
398
GPER mediates cardiotropic effects in spontaneously hypertensive rat hearts. 61
23950890 2013
399
Cardiovascular diseases in patients with rheumatoid arthritis. 61
23244227 2013
400
[Ischemic stroke with sinus rhythm in patients with arterial hypertension]. 61
23612393 2013
401
[Pleiotropic effects of atorvastatin and dynamics of quality of life characteristics in patients with hypertensive disease and metabolic syndrome]. 61
25702430 2013
402
Hypertensive disease in pregnancy: an examination of ethnic differences and the Hispanic paradox. 61
24246453 2013
403
[Alterations in the clinical course of hypertensive disease during the last 25 years]. 61
24437183 2013
404
[Is there an association of uric acid level with preclinical target organ damage in moderate- and high-risk hypertensive patients?]. 61
24261230 2013
405
[Clinical course and outcomes of myocardial infarction in women]. 61
24088002 2013
406
Cystic lymphangioma-like adenomatoid tumor of the adrenal gland: report of a rare case and review of the literature. 61
23638228 2013
407
[Profile of autonomous regulation of circulation in patients with severe left ventricular myocardial hypertension]. 61
23659072 2013
408
[24-hr monitoring arterial pressure in outpatients with cardiovascular risk factors in the Far North]. 61
25696949 2013
409
[Quality of life of patients with ischemic stroke in the vertebrobasilar system]. 61
24430051 2013
410
Cardiovascular disease and hip fracture among older inpatients in Beijing, China. 61
23936809 2013
411
Physiological, Behavioral, and Dietary Characteristics Associated with Hypertension among Kenyan Defence Forces. 61
24977096 2013
412
Sex differences in hypertension-related renal and cardiovascular diseases in Italy: the I-DEMAND study. 61
23137952 2012
413
Calcium supplementation and prevention of preeclampsia: a meta-analysis. 61
22889274 2012
414
[Hypertensive disease: diagnostics and differential methods of antihypertensive therapy]. 61
23301291 2012
415
Outcomes of gestational diabetes in Sweden depending on country of birth. 61
22882165 2012
416
Hypertension: quo vadis? 61
23259570 2012
417
Types of maternal hypertensive disease and their association with pathologic lesions and clinical factors. 61
22432966 2012
418
Inflammation and apoptosis in hypertension. Relevance of the extent of target organ damage. 61
22771083 2012
419
Reproductive outcomes after assisted conception. 61
22990460 2012
420
Vitamins E, A and B2 as Possible Risk Factors for Preeclampsia - under Consideration of the PROPER Study ("Prevention of Preeclampsia by High-Dose Riboflavin Supplementation"). 61
25308984 2012
421
An investigation of the stillbirths at a tertiary hospital in Limpopo province of South Africa. 61
23121750 2012
422
Pregnancies and their obstetric outcome in two selected age groups of teenage women in Greece. 61
22220679 2012
423
Uric acid: is it time to give up routine testing in management of pre-eclampsia? 61
27582868 2012
424
Relationships between vascular oxygen sensing mechanisms and hypertensive disease processes. 61
22710643 2012
425
[Syndrome and disease combination treatment of hypertensive disease]. 61
23173269 2012
426
Response to preeclampsia and hypertensive disease in pregnancy: their contributions to cardiovascular risk. 61
22508504 2012
427
Early neonatal outcome in late preterms. 61
22161578 2012
428
OS028. Hypertensive disease in pregnancy: An examination of ethnic differences and the Hispanic paradox. 61
26105242 2012
429
OS024. Characteristics and outcomes of critically ill obstetric patientswith hypertensive disease of pregnancy in argentina: Multicenter study. 61
26105238 2012
430
PP166. HELLP syndrome: Challenges for establishing diagnostic criteria. 61
26105487 2012
431
PP159. In women with previous pregnancy hypertension, cardiovascular risk biomarkers may be modulated by haptoglobin genotype. 61
26105480 2012
432
[Hypertensive crisis: problems of diagnostics and paradigm of the treatment]. 61
23038954 2012
433
PP028. To assess maternal and neonatal outcomes of women on an antihypertensive agent with gestational hypertension, chronic hypertension or preeclampsia. 61
26105351 2012
434
OS030. Hypertension and labor duration: Does it take longer? 61
26105244 2012
435
Hypertensive diseases in pregnancy and breast cancer risk. 61
22576589 2012
436
Prediction of recurrence of hypertensive disorders of pregnancy between 34 and 37 weeks of gestation: a retrospective cohort study. 61
22469065 2012
437
Prehypertension in adolescents: risk and progression. 61
22672089 2012
438
Single-nucleotide polymorphisms in the KDR gene in pregnancies complicated by gestational hypertensive disorders and small-for-gestational-age infants. 61
22344734 2012
439
[Review of mortality from hypertensive disease and diabetes mellitus after the error because of new death certificate: region of Murcia, Spain, 2009]. 61
22991080 2012
440
[Ultrasound and color Doppler applications in nephrology. The normal kidney: anatomy, vessels and congenital anomalies]. 61
22718458 2012
441
Mortality causes in cancer patients with type 2 diabetes mellitus. 61
21960185 2012
442
Increased Myogenic Reactivity of Uterine Arteries from Pregnant Rats with Reduced Uterine Perfusion Pressure. 61
22679605 2012
443
Introduction of automated blood pressure devices intended for a low resource setting in rural Tanzania. 61
22431828 2012
444
Regulation of monocyte chemoattractant protein-1 through angiotensin II type 1 receptor in prostate cancer. 61
22226738 2012
445
Preeclampsia and hypertensive disease in pregnancy: their contributions to cardiovascular risk. 61
22389120 2012
446
A minor role of WNK3 in regulating phosphorylation of renal NKCC2 and NCC co-transporters in vivo. 61
23213404 2012
447
[Diurnal profile of arterial pressure during sleep deprivation in patients with hypertensive disease receiving antihypertensive therapy]. 61
23019972 2012
448
[Metabolic disturbances as a factor of the pathogenesis of hypertensive disease and its clinical outcomes]. 61
23252248 2012
449
[Risk factors of development of left ventricular hypertrophy in patients with hypertensive disease with high compliance to treatment]. 61
22839513 2012
450
[The influence of vascular remodeling and endothelial vasomotor function on the efficacy of indapamide retard in patients with hypertensive disease]. 61
22567944 2012
451
Small intestinal edema had the strongest correlation with portal venous pressure amongst capsule endoscopy findings. 61
22710440 2012
452
Sympathetic nervous system: role in hypertension and in chronic kidney disease. 61
22080859 2012
453
[General pathological factors and problems of prevention and treatment of atherosclerosis and hypertensive disease]. 61
22567948 2012
454
Aggregation and deformability of erythrocytes in primary open-angle glaucoma (POAG); the assessment of arterial hypertension. 61
22330771 2012
455
The role of EEG brain mapping in quantification of brain damage in hypertensive disease associated with pregnancy. 61
23077894 2012
456
[Nonspecific inflammation and structural changes in the arteries of hypertensive males at high and moderate risk for cardiovascular events]. 61
23091854 2012
457
[Evaluation of the efficiency and safety of therapy with a combination of sulfonylurea derivatives and insulin sensitizers for type 2 diabetes mellitus]. 61
22994093 2012
458
[Newly developed atrial fibrillation among patients under active observation by an outpatient clinic]. 61
22304351 2012
459
[Quantitative characteristic of the regulatory and adaptive status for the estimation of severity of chronic cardiac failure]. 61
23101256 2012
460
[Advantages of quinapril therapy in patients with arterial hypertension and functional class III chronic heart failure with preserved left ventricular ejection fraction]. 61
22839514 2012
461
Risk factors for late postpartum preeclampsia. 61
22324265 2012
462
Mechanics and function of the pulmonary vasculature: implications for pulmonary vascular disease and right ventricular function. 61
23728987 2012
463
Mechanics and Function of the Pulmonary Vasculature: Implications for Pulmonary Vascular Disease and Right Ventricular Function. 61
23487595 2012
464
[Irbesartan in clinical practice]. 61